期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

STK15在乳癌组织中的表达 被引量：3

EXPRESSION OF STK15 IN BREAST CANCER
下载PDF
导出
摘要 目的探讨乳癌组织中癌基因STK15的表达情况。方法应用免疫组化SP法检测41例乳癌及30例乳腺纤维瘤组织中STK15蛋白的表达。结果 STK15蛋白在乳癌和乳腺纤维瘤组织中的阳性表达率分别为68.3%(28/41)、36.7%(11/30),二者之间差异有显著性(χ2=6.999,P<0.05)。STK15蛋白表达与乳癌的TNM分期及组织学分级有关(χ2=8.794、8.261,P<0.05),且STK15蛋白阳性表达强度与乳癌病人的TNM分期有关(χ2=5.895,P<0.05)。结论乳癌组织中存在STK15基因高表达,STK15基因可能是导致乳癌发生的因素之一。 Objective To investigate the expression of oncogene STK15 in breast cancer.Methods SP immunohistochemical method was used to determine the expression of STK15 in 41 cases of breast cancer and 30 cases of mammary fibroma.Results The positive rates of STK15 in breast cancer and mammary fibroma were 68.3%（28/41） and 36.7%（11/30）,respectively,the difference being statistically significant（χ^2=6.999,P〈0.05）.The expression of STK15 was related to the TNM staging and histology grading（χ^2=8.794,8.261;P〈0.05）,and its intensity of expression was associated with TNM staging as well（χ^2=5.895,P〈0.05）.Conclusion There is overexpression of STK15 gene in breast cancer,which may be one of the risk factors that result in the occurrence of this malignancy.
作者 方圣 曹明智 王群
机构地区 青岛大学医学院附属医院乳腺外科 蓬莱市人民医院普外科 青岛市骨伤医院普外科
出处 《齐鲁医学杂志》 2011年第6期484-485,488,共3页 Medical Journal of Qilu
关键词 乳腺肿瘤 基因 STK15 免疫组织化学 breast neoplasms gene STK15 immunohistochemistry
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1Flowmaster International LTD. Flowmaster2 Ver6. 1[S]. London, 2000.
  • 2ZHOU H, KUANG J, ZHONG L, et al. Tumor amplified ki nase STK15/BTAK induces centrosome amplification, aneu ploidy and transformation[J]. Nat Genet, 1998,20 (2) : 189-193.
  • 3黄官升.[D].北京:北京理工大学,2001.
  • 4DOXSEY S. The centrosome-a tiny organelle with big poten tial[J].. NatGenet, 1998,20:104-106.
  • 5LINGLE W L, LUTZ W H, INGLE J N. Centrosome hyper trophy in human breast tumors: implications forge nomic sta bility and cell polarity[J]. Proe Natl Acad Sei USA, 1998,95 (6) : 2950-2955.
  • 6SATO N, MIZUTO K, NAKAMURA M. Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells[J]. Cancer Genet Cytogenet, 2001,126(1):13 -19.
  • 7GUSTAFSON L M, GLEICH L L, FUKASAWA K. Centro- some hyperamplication in head and neck squamous cell carcinoma: a protential phenotypic marker of tumor aggressimeness [J]. Laryngoscope, 2000,110(11) : 1798-1801.
  • 8赵旭,李福才,李英惠,徐振明,孙开来.CORRELATION ANALYSIS BETWEEN STK15 GENE AND LARYNGEAL CARCINOMA[J].Chinese Journal of Cancer Research,2004,16(2):90-92. 被引量：1
  • 9SMITH M W, YUE Z N, GEISS G K. Identification of novel tumor markers in hepatitis C virus associated hepatocellular carcinoma[J]. Cancer Res, 200:3,63(4):859-864.
  • 10ROJANALA S, HAN H, MUNOZ R M. The mitotic serine threonine kinase, Aurora 2, is a potential target for drug development in human pancreatic cancer[J]. Mol Cancer Ther, 2004,3(4):451-457.

二级参考文献17

  • 1[1]Zhou H, Kuang J, Zhong L, et al. Tumor amplified kinase STK15/BTAK induces centrosome amplification, a neuploidy and transformation[J]. Nat Genet 1998; 20: 189-93.
  • 2[2]Katayama H, Zhou H, Li Q, et al. Interaction and feedback regulation between STK15/BTAK/Aurora-A kinase and Protein phosphatase 1 through mitotic cell division cycle[J]. J Biol Chem 2001; 276: 46217-24.
  • 3[3]Meraldi P, Honda R, Nigg EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells[J]. EMBO J 2002; 21: 483-92.
  • 4[4]Tokuyama Y, Horn HF, Kawamura K, et al. Specific phosphorylation of nucleophosmin on Thr199 by cyclin-dependent Kinase 2-Cyclin E and its Role in Centrosome Duplication[J]. J Biol Chem 2001; 276: 21529-37.
  • 5[5]Doxsey S. The centrosome-a tiny organelle with big potential[J]. Nat Genet 1998; 20: 104-6.
  • 6[6]Kramer A, Neben K, Ho AD. Centrosome replication, genomic instability and cancer[J]. Leukemia 2002; 16: 767-75.
  • 7[7]Marx J. Do centrosome abnormalities lead to cancer[J]? Science 2001; 292(5516): 426-9.
  • 8[8]Ouyang X, Wang X, Xu K, et al. Effect of p53 on centrosome amplification in prostate cancer cells[J]. Biochim Biophys Acta 2001; 1541: 212-20.
  • 9[9]Lingle WL, Lutz WH, Ingle JN, et al. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity[J]. Proc Natl Acad Sci USA 1998; 95: 2950-5.
  • 10[10]Pihan G, Purohit A, Wallace J, et al. Centrosome defects and genetic instability in malignant tumors[J]. Cancer Res 1998; 58: 3974-85.

共引文献1

同被引文献27

  • 1MURAKAMI Y. Involvement of a cell adhesion molecule, TSLC1/IGSF4 in human oncogenesis[J]. Cancer Sci, 2005,96 (9) :543-552.
  • 2MURAKAMI Y, NOBUKUNI T, TAMURA K, et al. Lo calization of tumor suppressor activity important in nonsmall cell lung carcinoma on chromosome 11q[J]. Proc Natl Acad Sci USA, 1998,95(14):8153-8158.
  • 3FUKUHARA H, KURAMOCHI M, FUKAMI T, et al. Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer[J]. Jpn J Cancer Res, 2002,93(6) :605-609.
  • 4ALLINEN M, PERI L, KUJALA S, et al. Analysis of 11q21 24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation [J]. Genes Chromosomes& Cancer, 2002,34(4):384 389.
  • 5HONDA T, TAMURA G, WAKI T, et al. Hypermethyla- tion of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines[J]. Jpn J Cancer Res, 2002,93 (8) :857-860.
  • 6FUKAMI T, FUKUHARA H, KURAMOCHI M, et al. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines[J]. Int J Cancer, 2003, 107(1):53-59.
  • 7SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics, 2012[J]. CA: a Cancer Journal for Clinicians, 2010,62(1):10-29.
  • 8HAMBEK M, ADUNKA O, BAGHI M, et al. AdOnco: a database for clinical and scientific documentation of head and neck oncologyEJ]. Annals of Otology, Rhinology, :. Laryn- gology, 2006,115(2):144-149.
  • 9TAKAI K, SAWAZAKI M, TOMARI S, et al. Developraent of a new data entry system suitable for the Japan Adult Cardio- vascular Surgery Database[J]. General Thoracic and Cardio- vascular Surgery, 2009,57(4) :192-196.
  • 10EL-HAYES K, HARRITY C, ABU ZEINEH T. A novel management database in obstetrics and gynaecology to intro- duce the electronic healthcare record and improve the clinical audit process[J]. Studies in Health Technology and Informa- tics, 2006,121:266 275.

引证文献3

二级引证文献5

齐鲁医学杂志
2011年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部